STAT | Reporting from the frontiers of health and medicine 中文 关注 STAT+:Talawar 押注双特异性疗法将撼动特应性皮炎市场 Moderna 对 mRNA 仍持乐观态度,Ipsen 收购 Kartos,以及来自《The Readout》的更多生物技术新闻 STAT+: Talawar bets bispecific approach can shake up eczema market statnews.com STAT | Reporting from the frontiers of health and medicine 中文 RSS thenote.app